{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:10:07Z","timestamp":1753891807949,"version":"3.41.2"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009101","name":"Education Department of Henan Province","doi-asserted-by":"publisher","award":["23A320016"],"award-info":[{"award-number":["23A320016"]}],"id":[{"id":"10.13039\/501100009101","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2023.1330225","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T17:26:30Z","timestamp":1702574790000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: Case reports in breast cancer : 2022"],"prefix":"10.3389","volume":"13","author":[{"given":"Nan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(54)90258-6","article-title":"Fibroma of the ovary with ascites and hydrothorax; Meigs\u2019 syndrome","volume":"67","author":"Meigs","year":"1954","journal-title":"Am J Obstet Gynecol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(16)33939-4","article-title":"Benign ovarian stromal tumors associated with free peritoneal fluid","volume":"107","author":"Samanth","year":"1970","journal-title":"Am J Obstet Gynecol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(01)01602-7","article-title":"The role of inflammatory cytokines in Meigs\u2019 syndrome","volume":"99","author":"Abramov","year":"2002","journal-title":"Obstet Gynecol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2325\/jbcs.13.344","article-title":"Pseudo-Meigs\u2019 syndrome caused by breast cancer metastasis to both ovaries","volume":"13","author":"Fujii","year":"2006","journal-title":"Breast Cancer (Tokyo Japan)."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2012.15.4.474","article-title":"A case of pseudo-meigs\u2019 syndrome associated with ovarian metastases from breast cancer","volume":"15","author":"Naito","year":"2012","journal-title":"J Breast Cancer."},{"key":"B6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3892\/mco.2021.2297","article-title":"Ovarian metastasis from breast cancer mimicking a primary ovarian neoplasm: A case report","volume":"15","author":"Akizawa","year":"2021","journal-title":"Mol Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-009-4187-2","article-title":"Pseudo-Meigs\u2019 syndrome associated with breast cancer metastasis to both ovaries: Report of a case","volume":"40","author":"Kawakubo","year":"2010","journal-title":"Surg Today"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0767-4","article-title":"The effects of tamoxifen on plasma lipoprotein(a) concentrations: systematic review and meta-analysis","volume":"77","author":"Sahebkar","year":"2017","journal-title":"Drugs"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2002.14.3.309","article-title":"Asymptomatic acute pancreatitis due to tamoxifen-induced severe hypertriglyceridemia in a patient with diabetes mellitus and breast cancer","volume":"14","author":"Artac","year":"2002","journal-title":"J Chemother (Florence Italy)."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajg.2011.01.003","article-title":"Incidence and risk factors for non-alcoholic steatohepatitis in females treated with tamoxifen for breast cancer","volume":"12","author":"Akhondi-Meybodi","year":"2011","journal-title":"Arab J Gastroenterol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2008.09.007","article-title":"Effects of hormonal treatment on lipids in patients with cancer","volume":"35","author":"Filippatos","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.6092\/1590-8577\/3626","article-title":"Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia with positive rechallenge","volume":"11","author":"Sakhri","year":"2010","journal-title":"JOP: J Pancreas"},{"key":"B13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2165\/00044011-200626050-00007","article-title":"Tamoxifen-induced severe hypertriglyceridaemia and acute pancreatitis","volume":"26","author":"Alagozlu","year":"2006","journal-title":"Clin Drug Invest"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2021.111680","article-title":"The effect of tamoxifen on the lipid profile in women: A systematic review and meta-analysis of randomized controlled trials","volume":"159","author":"Alomar","year":"2022","journal-title":"Exp Gerontol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1200\/jco.18.01100","article-title":"RECIST 1.1 for response evaluation apply not only to chemotherapy-treated patients but also to targeted cancer agents: A pooled database analysis","volume":"37","author":"Liti\u00e8re","year":"2019","journal-title":"J Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(99)00229-4","article-title":"Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations","volume":"35","author":"Young","year":"1999","journal-title":"Eur J Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.057307","article-title":"Lodge MAJJonm. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.092734","article-title":"PET imaging of estrogen receptors as a diagnostic tool for breast cancer patients presenting with a clinical dilemma","volume":"53","author":"van Kruchten","year":"2012","journal-title":"J Nucl Med"},{"key":"B19","article-title":"Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma","volume":"32","author":"McGuire","year":"1991","journal-title":"J Nucl Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.169.1.3262228","article-title":"Breast cancer: PET imaging of estrogen receptors","volume":"169","author":"Mintun","year":"1988","journal-title":"Radiol Oct"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109821","article-title":"Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET\/CT and [18F]Fluorodeoxyglucose PET\/CT","volume":"141","author":"Bottoni","year":"2021","journal-title":"Eur J Radiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.247882","article-title":"Head-to-head evaluation of (18)F-FES and (18)F-FDG PET\/CT in metastatic invasive lobular breast cancer","volume":"62","author":"Ulaner","year":"2021","journal-title":"J Nucl Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv022","article-title":"Genetics of breast cancer: a topic in evolution","volume":"26","author":"Shiovitz","year":"2015","journal-title":"Ann Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2004.tb02195.x","article-title":"Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage","volume":"95","author":"Yoshida","year":"2004","journal-title":"Cancer science. Nov"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3390\/ph14121270","article-title":"Expanding the use of PARP inhibitors as monotherapy and in combination in triple-negative breast cancer","volume":"14","author":"Yordanova","year":"2021","journal-title":"Pharm (Basel Switzerland)."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102597","article-title":"Current indications and future perspectives for antibody-drug conjugates in brain metastases of breast cancer","volume":"119","author":"Epaillard","year":"2023","journal-title":"Cancer Treat Rev"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.09.004","article-title":"Sacituzumab govitecan in previously treated hormone receptor-positive\/HER2-negative metastatic breast cancer: final results from a phase I\/II, single-arm, basket trial","volume":"31","author":"Kalinsky","year":"2020","journal-title":"Ann Oncol"},{"key":"B28","article-title":"Update on intraoperative radiotherapy for early-stage breast cancer","volume":"10","author":"Feng","year":"2020","journal-title":"Am J Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2016.1253876","article-title":"Ultrasound-guided microwave ablation: a promising tool in management of benign breast tumours","volume":"33","author":"Zhou","year":"2017","journal-title":"Int J Hyperthermia"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2018.1442589","article-title":"Technical analysis of US imaging for precise microwave ablation for benign breast tumours","volume":"34","author":"Li","year":"2018","journal-title":"Int J Hyperthermia"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s40349-017-0097-8","article-title":"Ablative techniques for the treatment of benign and Malignant breast tumours","volume":"5","author":"Peek","year":"2017","journal-title":"J Ther Ultrasound"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1330225\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T17:26:36Z","timestamp":1702574796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1330225\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":31,"alternative-id":["10.3389\/fonc.2023.1330225"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1330225","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2023,12,14]]},"article-number":"1330225"}}